SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-004908
Filing Date
2021-11-24
Accepted
2021-11-24 16:21:18
Documents
76
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q aura-20210930.htm   iXBRL 10-Q 3091981
2 EX-31.1 aura-ex31_1.htm EX-31.1 20965
3 EX-31.2 aura-ex31_2.htm EX-31.2 20921
4 EX-32.1 aura-ex32_1.htm EX-32.1 20247
  Complete submission text file 0000950170-21-004908.txt   9539670

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT aura-20210930_cal.xml EX-101.CAL 42046
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aura-20210930_pre.xml EX-101.PRE 354624
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aura-20210930_lab.xml EX-101.LAB 458184
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aura-20210930.xsd EX-101.SCH 60438
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT aura-20210930_def.xml EX-101.DEF 237674
10 EXTRACTED XBRL INSTANCE DOCUMENT aura-20210930_htm.xml XML 1539797
Mailing Address 85 BOLTON STREET CAMBRIDGE MA 02140
Business Address 85 BOLTON STREET CAMBRIDGE MA 02140 (617)500-8864
Aura Biosciences, Inc. (Filer) CIK: 0001501796 (see all company filings)

IRS No.: 320271970 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40971 | Film No.: 211447032
SIC: 2836 Biological Products, (No Diagnostic Substances)